Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nexium QD vs Lansoprazole BID for Severe GERD
NCT00295685Phase 4Completed
- Sponsor
- Digestive & Liver Disease Specialists
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of esomeprazole in gastroesophageal reflux disease (GERD), sponsored by Digestive & Liver Disease Specialists. Started Oct 2005; status: completed.
02
Drugs
esomeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00295685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00295685.